ALLISON REISS

Summary

Affiliation: Winthrop University Hospital
Country: USA

Publications

  1. pmc Infliximab reverses suppression of cholesterol efflux proteins by TNF-α: a possible mechanism for modulation of atherogenesis
    Iryna Voloshyna
    Winthrop Research Institute and Division of Rheumatology, Allergy and Immunology, Department of Medicine, Winthrop University Hospital, 222 Station Plaza North, Suite 502, Mineola, NY 11501, USA
    Biomed Res Int 2014:312647. 2014
  2. pmc Methotrexate in atherogenesis and cholesterol metabolism
    Eric Coomes
    Department of Medicine, Division of Translational Medicine, New York University School of Medicine, NBV 16N1, 550 First Avenue, New York, NY 10016, USA
    Cholesterol 2011:503028. 2011
  3. pmc Regulation of cerebral cholesterol metabolism in Alzheimer disease
    Allison B Reiss
    Winthrop Research Institute, Department of Medicine, Winthrop University Hospital, Mineola, NY 11501, USA
    J Investig Med 60:576-82. 2012
  4. pmc Effect of cyclooxygenase inhibition on cholesterol efflux proteins and atheromatous foam cell transformation in THP-1 human macrophages: a possible mechanism for increased cardiovascular risk
    Edwin S L Chan
    Division of Clinical Pharmacology, Department of Medicine, New York University School of Medicine, New York, NY 10016, USA
    Arthritis Res Ther 9:R4. 2007
  5. ncbi request reprint Enhanced CD36 scavenger receptor expression in THP-1 human monocytes in the presence of lupus plasma: linking autoimmunity and atherosclerosis
    Allison B Reiss
    Vascular Biology Institute, Department of Medicine, Winthrop University Hospital, 222 Station Plaza, North, Suite 502, Mineola, NY 11501, USA
    Exp Biol Med (Maywood) 234:354-60. 2009
  6. ncbi request reprint Disruption of cholesterol efflux by coxib medications and inflammatory processes: link to increased cardiovascular risk
    Allison B Reiss
    Vascular Biology Institute, Department of Medicine, Winthrop University Hospital, Mineola, NY, and Department of Medicine, NYU School of Medicine, New York, NY, USA
    J Investig Med 57:695-702. 2009
  7. pmc Plasma from systemic lupus patients compromises cholesterol homeostasis: a potential mechanism linking autoimmunity to atherosclerotic cardiovascular disease
    Allison B Reiss
    Department of Medicine, Vascular Biology Institute, Division of Rheumatology, Allergy and Immunology, Winthrop University Hospital, 222 Station Plaza, North, Suite 502, Mineola, NY 11501, USA
    Rheumatol Int 30:591-8. 2010
  8. ncbi request reprint Lectin-like oxidized low density lipoprotein receptor 1 (LOX-1) in atherogenesis: a brief review
    Allison B Reiss
    Vascular Biology Institute, Department of Medicine, Winthrop University Hospital, Suite 502, Mineola, NY 11501, USA
    Curr Med Chem 16:2641-52. 2009
  9. ncbi request reprint Effects of inflammation on cholesterol metabolism: impact on systemic lupus erythematosus
    Allison B Reiss
    Vascular Biology Institute, Department of Medicine, Winthrop University Hospital, Suite 502, Mineola, NY 11501, USA
    Curr Rheumatol Rep 11:255-60. 2009
  10. ncbi request reprint Statins in neurological disorders: mechanisms and therapeutic value
    Allison B Reiss
    Vascular Biology Institute and 2Division of Neurology, Department of Medicine, Winthrop University Hospital, Mineola, New York, USA
    ScientificWorldJournal 9:1242-59. 2009

Research Grants

Detail Information

Publications24

  1. pmc Infliximab reverses suppression of cholesterol efflux proteins by TNF-α: a possible mechanism for modulation of atherogenesis
    Iryna Voloshyna
    Winthrop Research Institute and Division of Rheumatology, Allergy and Immunology, Department of Medicine, Winthrop University Hospital, 222 Station Plaza North, Suite 502, Mineola, NY 11501, USA
    Biomed Res Int 2014:312647. 2014
    ..The anti-TNF drug infliximab, commonly used in rheumatology, restored RCT proteins. This is the first report of an atheroprotective effect of infliximab on RCT in monocytes...
  2. pmc Methotrexate in atherogenesis and cholesterol metabolism
    Eric Coomes
    Department of Medicine, Division of Translational Medicine, New York University School of Medicine, NBV 16N1, 550 First Avenue, New York, NY 10016, USA
    Cholesterol 2011:503028. 2011
    ..Elucidating underlying cardiovascular mechanisms of these drugs provides a framework for developing novel cardioprotective anti-inflammatory medications, such as selective A(2A) receptor agonists...
  3. pmc Regulation of cerebral cholesterol metabolism in Alzheimer disease
    Allison B Reiss
    Winthrop Research Institute, Department of Medicine, Winthrop University Hospital, Mineola, NY 11501, USA
    J Investig Med 60:576-82. 2012
    ..This review summarizes the current state of our knowledge of the influence of cholesterol and lipid pathways in AD pathogenesis in vitro and in vivo...
  4. pmc Effect of cyclooxygenase inhibition on cholesterol efflux proteins and atheromatous foam cell transformation in THP-1 human macrophages: a possible mechanism for increased cardiovascular risk
    Edwin S L Chan
    Division of Clinical Pharmacology, Department of Medicine, New York University School of Medicine, New York, NY 10016, USA
    Arthritis Res Ther 9:R4. 2007
    ..NS398-treated THP-1 macrophages show greater vulnerability to form foam cells. Increased cardiovascular risk with COX inhibition may be ascribed at least in part to altered cholesterol metabolism...
  5. ncbi request reprint Enhanced CD36 scavenger receptor expression in THP-1 human monocytes in the presence of lupus plasma: linking autoimmunity and atherosclerosis
    Allison B Reiss
    Vascular Biology Institute, Department of Medicine, Winthrop University Hospital, 222 Station Plaza, North, Suite 502, Mineola, NY 11501, USA
    Exp Biol Med (Maywood) 234:354-60. 2009
    ..CD36 may provide a novel therapeutic target in the treatment of ASCVD in SLE patients...
  6. ncbi request reprint Disruption of cholesterol efflux by coxib medications and inflammatory processes: link to increased cardiovascular risk
    Allison B Reiss
    Vascular Biology Institute, Department of Medicine, Winthrop University Hospital, Mineola, NY, and Department of Medicine, NYU School of Medicine, New York, NY, USA
    J Investig Med 57:695-702. 2009
    ..We explore the relationship between suppression of reverse cholesterol transport and harmful cardiac effects of coxibs...
  7. pmc Plasma from systemic lupus patients compromises cholesterol homeostasis: a potential mechanism linking autoimmunity to atherosclerotic cardiovascular disease
    Allison B Reiss
    Department of Medicine, Vascular Biology Institute, Division of Rheumatology, Allergy and Immunology, Winthrop University Hospital, 222 Station Plaza, North, Suite 502, Mineola, NY 11501, USA
    Rheumatol Int 30:591-8. 2010
    ..001). Impaired cholesterol homeostasis in SLE provides further evidence of immune involvement in atherogenesis. Strategies to inhibit or reverse arterial cholesterol accumulation may benefit SLE patients...
  8. ncbi request reprint Lectin-like oxidized low density lipoprotein receptor 1 (LOX-1) in atherogenesis: a brief review
    Allison B Reiss
    Vascular Biology Institute, Department of Medicine, Winthrop University Hospital, Suite 502, Mineola, NY 11501, USA
    Curr Med Chem 16:2641-52. 2009
    ..The ability of LOX-1 to bind many different ligands and control several atherogenic processes makes this receptor a likely vascular disease biomarker as well as an ideal choice for drug therapy aimed at preventing cardiovascular disease...
  9. ncbi request reprint Effects of inflammation on cholesterol metabolism: impact on systemic lupus erythematosus
    Allison B Reiss
    Vascular Biology Institute, Department of Medicine, Winthrop University Hospital, Suite 502, Mineola, NY 11501, USA
    Curr Rheumatol Rep 11:255-60. 2009
    ..The impact of lupus on each of these components of the cholesterol flux pathways is discussed. The formation of autoantibodies against epitopes within lipoprotein particles and their controversial role in atherogenesis is addressed...
  10. ncbi request reprint Statins in neurological disorders: mechanisms and therapeutic value
    Allison B Reiss
    Vascular Biology Institute and 2Division of Neurology, Department of Medicine, Winthrop University Hospital, Mineola, New York, USA
    ScientificWorldJournal 9:1242-59. 2009
    ..In this review, we discuss the potential reasons for the effect of statins on stroke and AD, and the multiple mechanisms of action of this class of lipid-lowering drugs...
  11. pmc Atheroprotective effects of methotrexate on reverse cholesterol transport proteins and foam cell transformation in human THP-1 monocyte/macrophages
    Allison B Reiss
    Vascular Biology Institute, Winthrop University Hospital, Mineola, New York 11501, USA
    Arthritis Rheum 58:3675-83. 2008
    ....
  12. ncbi request reprint Role of HMG-CoA reductase inhibitors in neurological disorders : progress to date
    Allison B Reiss
    SUNY Stony Brook School of Medicine, Vascular Biology Institute, Winthrop University Hospital, Mineola, NY 11501, USA
    Drugs 67:2111-20. 2007
    ..The appropriateness of initiating statin therapy for neurological disorders is not established at this time. The exception is stroke, in which recurrence is significantly reduced by statin therapy...
  13. ncbi request reprint Interferon-gamma impedes reverse cholesterol transport and promotes foam cell transformation in THP-1 human monocytes/macrophages
    Allison B Reiss
    Department of Vascular Biology, Winthrop University Hospital, Mineola, NY 11501, USA
    Med Sci Monit 10:BR420-5. 2004
    ..We therefore examined the effect of IFN-g on macrophage foam cell formation and on expression of the anti-atherogenic 27-hydroxylase in THP-1 human monocytes/macrophages...
  14. ncbi request reprint Atherosclerosis: immune and inflammatory aspects
    Allison B Reiss
    Vascular Biology Institute, Winthrop University Hospital, 222 Station Plaza, North, Suite 511 A, Mineola, NY 11501, USA
    J Investig Med 54:123-31. 2006
    ..Emphasis is placed on the role of inflammation as a driving force in the process of atherosclerosis and vascular endothelium as a modulating factor in the pathogenesis of coronary artery disease...
  15. ncbi request reprint Recent insights into the role of prostanoids in atherosclerotic vascular disease
    Allison B Reiss
    Department of Medicine, Vascular Biology Institute, Winthrop University Hospital, 222 Station Plaza, North Mineola, NY 11501, USA
    Curr Vasc Pharmacol 4:395-408. 2006
    ..Finally, we investigate original therapeutic modalities of various prostanoids involved in the aforementioned diseases...
  16. ncbi request reprint PPARgamma activity in the vessel wall: anti-atherogenic properties
    Allison B Reiss
    Vascular Biology Institute, Department of Medicine, Winthrop University Hospital, 222 Station Plaza North, Mineola, NY 11501, USA
    Curr Med Chem 13:3227-38. 2006
    ..We provide an overview of in vitro and in vivo data in cell lines, animal models, and humans demonstrating the ways in which PPARgamma activation alters the biology of the arterial wall...
  17. ncbi request reprint Adenosine A2A receptor occupancy stimulates expression of proteins involved in reverse cholesterol transport and inhibits foam cell formation in macrophages
    Allison B Reiss
    Department of Medicine, New York University School of Medicine, New York, NY, USA
    J Leukoc Biol 76:727-34. 2004
    ..These findings suggest a novel approach to the development of agents that prevent progression of atherosclerosis...
  18. pmc A2A adenosine receptor stimulation decreases foam cell formation by enhancing ABCA1-dependent cholesterol efflux
    Taiese Crystal Bingham
    Department of Medicine, New York University School of Medicine, New York, New York, USA
    J Leukoc Biol 87:683-90. 2010
    ..0007 vs. control; n=3) and phospho-ABCA1 (13+5%; P<0.0003 vs. control; n=3) protein. These results demonstrate that A2AR occupancy diminishes foam cell formation by stimulating increased reverse cholesterol transport via ABCA1...
  19. pmc Cholesterol 27-hydroxylase but not apolipoprotein apoE contributes to A2A adenosine receptor stimulated reverse cholesterol transport
    Taiese Crystal Bingham
    Department of Medicine, New York University School of Medicine, 550 First Avenue, New York, NY 10016, USA
    Inflammation 35:49-57. 2012
    ..These results demonstrate that adenosine A(2A) receptor occupancy diminishes foam cell formation by increasing expression and function of CYP27A1...
  20. ncbi request reprint Cholesterol and apolipoprotein E in Alzheimer's disease
    Allison B Reiss
    Vascular Biology Institute, Department of Medicine, Winthrop University Hospital, Mineola, New York, USA
    Am J Alzheimers Dis Other Demen 20:91-6. 2005
    ..ApoE, which transports cholesterol throughout the brain, exhibits an isoform-specific association with AD such that the E4 isoform, by unknown mechanisms, shifts the onset curve toward an earlier age...
  21. ncbi request reprint Cholesterol in neurologic disorders of the elderly: stroke and Alzheimer's disease
    Allison B Reiss
    Department of Medicine, New York University School of Medicine, New Bellevue 16N1, 550 First Avenue, New York, NY 10016, USA
    Neurobiol Aging 25:977-89. 2004
    ..The reduction in stroke and AD risk in patients treated with cholesterol-lowering statins is also discussed...
  22. pmc Adenosine A(2A) receptors play a role in the pathogenesis of hepatic cirrhosis
    Edwin S L Chan
    Division of Clinical Pharmacology, Department of Medicine, New York University School of Medicine, New York, NY 10016, USA
    Br J Pharmacol 148:1144-55. 2006
    ..6. These results demonstrate that hepatic adenosine A(2A) receptors play an active role in the pathogenesis of hepatic fibrosis, and suggest a novel therapeutic target in the treatment and prevention of hepatic cirrhosis...
  23. ncbi request reprint Oxysterol derivatives of cholesterol in neurodegenerative disorders
    T M Jeitner
    Department of Medicine, Winthrop University Hospital, 222 Station Plaza, North, Suite 502, Mineola, NY 11501, USA
    Curr Med Chem 18:1515-25. 2011
    ..The following article provides an overview of the involvement of oxysterols in Alzheimer's disease, multiple sclerosis and spastic paraplegias...
  24. ncbi request reprint Differential expression of cholesterol hydroxylases in Alzheimer's disease
    James Brown
    Departments of Pharmacology and Pathology, Loyola University Medical Center, Maywood, IL 60153, USA
    J Biol Chem 279:34674-81. 2004
    ....

Research Grants3

  1. Immune Reactants, Cholesterol and Atherosclerosis
    ALLISON REISS; Fiscal Year: 2004
    ..abstract_text> ..
  2. Immune Reactants, Cholesterol and Atherosclerosis
    ALLISON REISS; Fiscal Year: 2005
    ..abstract_text> ..
  3. Immune Reactants, Cholesterol and Atherosclerosis
    ALLISON REISS; Fiscal Year: 2006
    ..abstract_text> ..